The PRECISE trial - Pain RElief Combination Intervention StragEgies
PRECISE 试验 - 疼痛缓解组合干预策略
基本信息
- 批准号:442962
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2020
- 资助国家:加拿大
- 起止时间:2020-10-01 至 2021-10-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Chronic pain affects 20-30% of Canadians, costs >$650 billion/year in North America and is recognized as a disease in its own right. Current therapies have limited efficacy and tolerability. Rational, carefully supervised, combination therapy with differe
慢性疼痛影响着20-30%的加拿大人,在北美每年造成6500亿美元的损失,本身就被认为是一种疾病。目前的治疗方法疗效和耐受性有限。理性、严密监督、区别对待的联合治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gilron Ian其他文献
Gilron Ian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gilron Ian', 18)}}的其他基金
The PRECISE trial - Pain RElief Combination Intervention StratEgies
PRECISE 试验 - 疼痛缓解组合干预策略
- 批准号:
488550 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
PAin Improvement with Novel Combination Analgesic REgimens: The PAIN-CARE Trial
通过新型组合镇痛方案改善疼痛:疼痛护理试验
- 批准号:
342803 - 财政年份:2016
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Combination pharmacotherapy for the management of pain in fibromyalgia
治疗纤维肌痛疼痛的联合药物疗法
- 批准号:
200698 - 财政年份:2010
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Combination pharmacotherapy for the management of pain in fibromyalgia
治疗纤维肌痛疼痛的联合药物疗法
- 批准号:
199322 - 财政年份:2009
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Combination pharmacotherapy for the management of pain (2008)
治疗疼痛的联合药物疗法 (2008)
- 批准号:
170474 - 财政年份:2008
- 资助金额:
$ 7.29万 - 项目类别:
Randomized Controlled Trials
相似海外基金
The role of LILRB3-mediated immunomodulation on myeloid cells and exploration of new combination therapy for chronic inflammation and cancer
LILRB3介导的免疫调节对骨髓细胞的作用及慢性炎症和癌症联合治疗的探索
- 批准号:
24K18478 - 财政年份:2024
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identification of novel therapeutic target and mechanism for PARP inhibitor combination therapy
PARP抑制剂联合治疗的新治疗靶点和机制的鉴定
- 批准号:
23K08100 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fundamental research for the application of effective combination therapy of sarcomatoid kidney cancer to bone and soft tissue sarcoma
肉瘤样肾癌有效联合治疗骨软组织肉瘤应用的基础研究
- 批准号:
23K08696 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combination therapy for renal cell carcinoma using oncolytic virus G47d
使用溶瘤病毒 G47d 联合治疗肾细胞癌
- 批准号:
23K08752 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism-based combination therapy for cholangiocarcinoma
基于机制的胆管癌联合治疗
- 批准号:
10650049 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
MRI Study of Hydrogen Water and Minocycline Combination Therapy for Ischemic Stroke
氢水与米诺环素联合治疗缺血性中风的MRI研究
- 批准号:
10564735 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Development of novel combination therapy of chimeric antigen receptor T cells and HMG-CoA reductase inhibitors (statin)
嵌合抗原受体T细胞和HMG-CoA还原酶抑制剂(他汀类药物)的新型联合疗法的开发
- 批准号:
23K15306 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel Combination Therapy for Treatment and Prevention of PulmonaryLymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC)
治疗和预防肺淋巴管平滑肌瘤病 (LAM) 和结节性硬化症 (TSC) 的新型联合疗法
- 批准号:
10697901 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Association between efficacy of Immuno-Oncology combination therapy for renal cell carcinoma and gut microbiota including fungi and viruses
肾细胞癌免疫肿瘤联合疗法的疗效与肠道微生物群(包括真菌和病毒)之间的关联
- 批准号:
23K08749 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




